-
-
-
-
-
-
-
TScan Therapeutics, Inc (TCRX) Announces Pricing of Upsized $150 Million Public Offering
-
-
-
-
-
-
-
TScan Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
-
-
20,596 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

